Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PTEN function in mammalian cell size regulation.

Stéphanie Backman1, Vuk Stambolic, Tak Mak

  • 1Department of Medical Biophysics, University of Toronto and Ontario Cancer Institute, 610 University Avenue, Toronto, Canada. sbackman@uhnres.utoronto.edu

Current Opinion in Neurobiology
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32.

JNCI cancer spectrum·2026
Same author

Exploration of BMI and circulating metabolic factors as predictors of metformin benefit in CCTG MA.32.

JNCI cancer spectrum·2026
Same author

Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

Cell reports. Medicine·2026
Same author

β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Insulin receptor loss impairs mammary tumorigenesis in mice.

Cell reports·2023
Same author

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

The PTEN gene, a tumor suppressor, controls neuron size and is linked to Lhermitte-Duclos disease. It may regulate cell size by affecting protein translation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Oncology

Background:

  • The PTEN gene acts as a tumor suppressor.
  • PTEN is a lipid phosphatase regulating the phosphatidylinositol 3-kinase-protein kinase B/Akt signaling pathway, which controls cell survival.
  • Recent studies indicate PTEN's role in neuronal size control.

Purpose of the Study:

  • To investigate the role of PTEN in regulating neuronal cell size.
  • To explore the connection between PTEN dysregulation and Lhermitte-Duclos disease.
  • To understand the molecular mechanisms by which PTEN influences cell size, potentially through protein translation.

Main Methods:

  • In vivo studies were conducted to observe PTEN's function in neurons.
  • Analysis of PTEN's involvement in the phosphatidylinositol 3-kinase-protein kinase B/Akt signaling pathway.

Related Experiment Videos

  • Investigation into PTEN's potential regulation of protein translation.

    • Main Results:

    • PTEN was found to play a novel role in controlling the size of neurons.
    • Dysregulation of PTEN's cell growth control is associated with Lhermitte-Duclos disease.
    • Evidence suggests PTEN influences cell size potentially via modulation of protein translation.

    Conclusions:

    • PTEN is a critical regulator of neuronal size.
    • PTEN's function in cell growth control is vital for preventing neurological disorders like Lhermitte-Duclos disease.
    • Targeting PTEN-mediated protein translation may offer therapeutic strategies for related neurological conditions.